Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-03-02 @ 6:08 PM
Study NCT ID:
NCT02345460
Status:
TERMINATED
Last Update Posted:
2018-07-13
First Post:
2015-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study
Sponsor:
Case Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09
Start Date Type:
None
Primary Completion Date:
2016-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03
Completion Date Type:
ACTUAL
First Submit Date:
2015-01-20
First Submit QC Date:
None
Study First Post Date:
2015-01-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-06-13
Results First Submit QC Date:
None
Results First Post Date:
2018-07-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-13
Last Update Post Date:
2018-07-13
Last Update Post Date Type:
ACTUAL